欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/0154/001
药品名称Tetravac
活性成分
    • clostridium tetani Toxoid 1.0 -
    • diphtheria toxoid, adsorbed 1.0 -
    • Pertussis toxoid 1.0 -
    • Polio virus type 1, inactivated 1.0 -
    • Polio virus type 2, inactivated 1.0 -
    • Polio virus type 3, inactivated 1.0 -
剂型Suspension for injection
上市许可持有人Sanofi Pasteur Europe, France
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Italy (IT)
    • Greece (GR)
    • Finland (FI)
    • Iceland (IS)
    • Norway (NO)
    • Denmark (DK)
    • Belgium (BE)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Portugal (PT)
许可日期1998/08/03
最近更新日期2025/02/10
药物ATC编码
    • J07CA02 diphtheria-pertussis-poliomyelitis-tetanus
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase